TABLE 1.
Clinical and demographic characteristics of the patients
| CD (N = 128) | UC (N = 117) | CD and UC (N = 245) | Anti‐TNF naive (N = 104) | Anti‐TNF experienced (N = 141) | |
|---|---|---|---|---|---|
| Age (years), M ± SD | 41.98 ± 15.29 | 46.08 ± 15.42 | 43.93 ± 15.46 | 44.71 ± 16.28 | 43.35 ± 14.85 |
| Sex (%) | |||||
| Male | 61 (47.7) | 53 (45.3) | 114 (46.5) | 50 (48.1) | 64 (45.4) |
| Female | 67 (52.3) | 64 (54.7) | 131 (53.5) | 54 (51.9) | 77 (54.6) |
| Duration of disease (years), M ± SD | 12.46 ± 9.22 | 11.03 ± 8.58 | 11.78 ± 8.93 | 9.68 ± 8.44 | 13.34 ± 8.99 |
| Anti‐TNF experienced (%) | |||||
| Yes | 82 (64.1) | 59 (50.4) | 141 (57.6) | 141 | |
| No | 46 (35.9) | 58 (49.6) | 104 (42.4) | 104 | |
| Comedication IS at T0 | 27 (21.1) | 33 (28.2) | 60 (24.5) | 23 (22.1) | 37 (26.2) |
| Comedication oral steroids at T0 | 51 (39.8) | 45 (38.5) | 96 (39.2) | 30 (28.8) | 66 (46.8) |
| Montreal classification CD/UC (%) | |||||
| L1/E1 | 30 (23.4) | 15 (12.8) | |||
| L2/E2 | 26 (20.3) | 39 (33.4) | |||
| L3/E3 | 61 (47.7) | 63 (53.8) | |||
| L1 + L4 | 4 (3.1) | ||||
| L3 + L4 | 7 (5.5) | ||||
Abbreviations: CD, Crohn's disease; IS, immunosuppressives; SD, standard deviation; TNF, tumour necrosis factor; UC, ulcerative colitis.